Navigation Links
Quanta Appoints World Leading Nephrologist to Medical Advisory Board
Date:2/6/2017

ALCESTER, England, February 6, 2017 /PRNewswire/ --

Quanta Dialysis Technologies Ltd ("Quanta" or the "Company"), a medical device company providing innovative haemodialysis solutions for the clinic and the home, today announces it has appointed Dr Sandip Mitra to its Medical Advisory Board.

Sandip is a practising Senior Consultant Nephrologist at Manchester Royal Infirmary where he leads one of the largest home haemodialysis programmes in Europe. He is a Principal Investigator on multicentre trials and is a recognised international advisor to global industry leaders in dialysis. Over the past 12 years he has held a number of research and clinical positions, including Renal Speciality Research Lead for the Clinical Research Network NIHR; Chair of Clinical Research Study Group for the UK Kidney Research Consortium NIHR; Renal Innovation Lead at MAHSC & Manchester Integrating Medicine & Innovative Technology (MIMIT); Clinical Chair, Renal Technology at NIHR Devices for Dignity; Senior Lecturer at the University of Manchester; and Clinical and Governance Lead for the Hospital, Home and Minimal Care HD.

Sandip qualified as a doctor in India and has since received speciality training in nephrology in Stevenage, Oxford and Manchester. Sandip has written extensive research on uraemia and dialytic therapies at University College London, Royal Free Medical School. He was previously Senior Research Fellow UCL, Royal Free Hospitals and Lister Hospital in Hertfordshire. He has won multiple awards for his work, research and innovation, including the Health Service Top Innovator Award in 2013, National Award Winner of the NHS Innovation Challenge and NICE excellence Award in 2011 as well as the British Journal of Renal Medicine Awards in 2010.

John E. Milad, Chief Executive Officer of Quanta, said "We are delighted that Sandip has chosen to join our Medical Advisory Board. He is a world-leading nephrologist and understands that innovation is a powerful enabler for improving patient outcomes and experiences in dialysis, whilst achieving better value for money. Over the course of the last decade, Dr Mitra has been an effective champion of home dialysis and I look forward to working with him as we expand the use of SC+ within the NHS."

-ENDS- 

For more information about Quanta, please contact: 

Quanta John E. Milad, T: +44 (0)1789 400043 Chief Executive Officer E: enquiries@quantadt.com Consilium Strategic Communications T: +44 (0)203 709 5708 Julia Wilson / Matthew Neal / Lindsey Neville E: quanta@consilium-comms.com

About SC+
SC+ supports patients across the continuum of care from the clinic to the home. It is the only easy-to-use, compact, haemodialysis system offering high performance comparable to conventional devices and compatible with traditional treatment regimens used in-centre. The technology behind SC+ is based on an innovative and unique design that incorporates all fluid management activities onto a single-use disposable cartridge. This cartridge-based design is intended to reduce downtime, simplify treatment complexity and reduce the risk of contamination. SC+ has regulatory approval in Europe (CE Mark) and is currently being used to treat patients in the UK.

About Quanta
Quanta aims to improve the lives of dialysis patients by providing advanced haemodialysis solutions for use in the clinic and the home. The Company's lead product SC+ provides performance, flexibility and convenience to empower dialysis patients to regain control of their lives. Founded in 2008 and based in Alcester, UK, Quanta has attracted funding from a group of leading investors including: Stage Capital/NBGI Ventures, Wellington Partners, Seroba, b-to-v Partners, ALIAD, Seventure Partners and Kuwait Life Sciences Company, as well as IMI plc.

For more information, please visit: http://www.quantadt.com.



'/>"/>
SOURCE Quanta
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Quanta Treats First Patients with Advanced Haemodialysis System SC+
2. Quanta Receives £1.85 Million i4i Award to Develop an Advanced Haemodialysis System for Nocturnal Use
3. Inova Diagnostics receives FDA clearance for QUANTA Flash connective tissue disease assays and Beta-2 Glycoprotein1 Domain1, a novel marker for antiphospholipid syndrome
4. Quanta Aesthetic Lasers Expands North American Headquarters
5. Quanta Raises £27 Million to Prepare its Advanced Haemodialysis System SC+ for Launch
6. Another Italian Beauty Joins the Quanta Aesthetic Lasers Lineup
7. Quanta Establishes Medical Advisory Board of World-Leading Renal Experts
8. Quanta Appoints New Chief Financial Officer
9. Applied Silver Appoints New Advisor
10. Symic Bio Appoints Scott W. Morrison to Board of Directors
11. CTI BioPharma Appoints Leading BioPharma Executive Michael Metzger To Board Of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2020)... ... February 26, 2020 , ... Anchora Medical ... of a $4.5 million financing round led by HOYA Corporation (“HOYA”) (ADR: HOCPY, ... used to complete Anchora's family of single-use laparoscopic suturing devices. , HOYA, a ...
(Date:2/23/2020)... ... February 22, 2020 , ... The University of Minnesota’s Integrated ... Avoid a Food System Crisis ’ in Food Safety Magazine's February/March issue. ... Ligt , delves deep into the boundaries that food system leaders need to break ...
(Date:2/21/2020)... ... ... Nationwide jails are seeing higher rates of incarcerated people with serious mental ... no more likely to commit a crime than anyone else, when they do, they ... may be experiencing symptoms that lead to these types of crimes. Statistics show that ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... February 20, 2020 , ... Millennial women are flocking to ... Center in Milford, Penn requesting treatments to achieve “ Rich Girl Face .” In ... like it is slowing down into 2020. It’s a look inspired by the signature ...
(Date:2/19/2020)... MONROE, Conn. (PRWEB) , ... February 19, 2020 ... ... respected periodontists at Advanced Periodontics and Dental Implant Center of Connecticut, celebrate 30 ... all new patients with the same low fees that they charged in 1989, ...
(Date:2/19/2020)... ... February 19, 2020 , ... ... Founders Encouraged to Apply to Participate in 2020 Cohort , The Massachusetts Medical ... program is now accepting applications from startup founders and CEOs to participate ...
(Date:2/19/2020)... ... February 19, 2020 , ... Nvision ... its growing product portfolio for lower extremities at the American College of Foot ... Convention Center. The Trigon® Ti Stand-Alone Osteotomy Wedge Fixation System will lead Nvision's ...
(Date:2/16/2020)... ... February 16, 2020 , ... ... that it is partnering with AABB and The Joint Commission to provide a ... for PBM teams (directors, managers, coordinators and transfusion safety officers) within U.S. hospitals. ...
Breaking Medicine News(10 mins):